Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics

Daniel J. Smith, Alison C. Badrick, Martha Zakrzewski, Lutz Krause, Scott C. Bell, Gregory J. Anderson, David W. Reid
European Respiratory Journal 2014; DOI: 10.1183/09031936.00203013
Daniel J. Smith
1Dept of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia
2Iron Metabolism Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
3Lung, Inflammation and Infection Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
4School of Medicine, The University of Queensland, Brisbane, QLD, Australia
8Both authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison C. Badrick
2Iron Metabolism Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
3Lung, Inflammation and Infection Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
8Both authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martha Zakrzewski
5Bioinformatics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lutz Krause
5Bioinformatics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott C. Bell
1Dept of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia
4School of Medicine, The University of Queensland, Brisbane, QLD, Australia
6Queensland Children’s Medical Research Institute, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory J. Anderson
2Iron Metabolism Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
4School of Medicine, The University of Queensland, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David W. Reid
1Dept of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia
2Iron Metabolism Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
3Lung, Inflammation and Infection Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
4School of Medicine, The University of Queensland, Brisbane, QLD, Australia
7Menzies Research Institute, Royal Hobart Hospital, Hobart, TAS, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Additional Files

  • Supplementary material

    Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

    Files in this Data Supplement:

    • Table S1 - Intravenous antibiotic usage, standard microbiological cultures and sensitivity testing results
    • Table S2 - Demographics, lung function and antibiotic treatment of individual patients
    • Table S3 - Taxonomic classification of 16s rDNA reads
    • Figure S1 - Scatterplot matrix visualizing pairwise correlations between bacterial community diversity and composition, as well as subject demographics. The diagonal of the matrix lists the variables (grey boxes) compared in the scatterplots. Variables considered were FEV1, age, Shannon diversity and relative abundance of the most abundant bacterial genera. Each panel in the matrix contains a scatterplot for a pair of variables. Each dot in the scatterplots corresponds to the measurements of the variable for an individual subject and is coloured according to the hierarchical cluster (H, M, L) assigned to the subject at TP-1 . The scatterplots in the upper triangle (above the diagonal) or lower triangle (below the diagonal) illustrate the relationships of the variables at TP-1 and TP-3, respectively. The relationship between the relative abundance of Pseudomonas and microbial diversity was negatively correlated (Pearson, r=-0.87, p<0.01). A positive correlation was seen between microbial diversity and Streptococcocus (r=0.63, p<0.01) and Prevotella (r=0.6, p=0.01).
    • Figure S2 - Scatterplot matrix visualizing pairwise correlations of variables participant demographics and change in microbial composition between TP-1 and TP3. The diagonal of the matrix lists the variables (grey box) that were compared in the scatterplots. Variables included were; improvement in FEV1, age, change in Shannon diversity and change in relative abundance of selected bacterial genera. The change was determined by calculating the difference of the Shannon diversity or relative abundance of the genus between TP-1 and TP-3. Each dot in the scatterplots corresponds to the measurements of the variable for an individual subject and is coloured according to the hierarchical clustered (H, M, L) assigned to the subject at TP-1. The change in microbial diversity demonstrated a negative correlation with the relative abundance of Pseudomonas (Pearson, r=-0.76, p<0.001) and a positive correlation with the relative abundance of Streptococcus (r=0.6, p=0.01).
    • Figure S3 - PCoA (A) and hierarchical clustering of CF sputum samples based on OTU profiles (B) and categorization of subjects according to identified sputum microbiota groups (C). A. PCoA of the sputum microbiome showing a shift in the microbiota at TP-2 (rectangle). TP-1 (triangle) and TP-3 (circle) for some subjects clustered together indicating a return to the initial community composition. B. Only OTUs that had a relative abundance >10% in at least one sample are shown. Hierarchical clustering demonstrated grouping of samples based on the abundance of OTUs related to Pseudomonas spp: (L) Mixed community consisting of low levels of Pseudomonas and presence of several other bacterial groups, (M) Intermediate abundance of Pseudomonas and only minor other bacterial groups, (H) Pseudomonas-dominated samples. Group L can further be subdivided according to the prevalence of Staphylococcus and Fusobacterium (L1), Streptococcus (L2) and other unknown Gammaproteobacteria species (L3). C. The time-point (TP-1: green, TP-2: red, TP-3: blue) of the samples for each subject is categorized according to the groupings retrieved from hierarchical clustering. Subjects are stratified by order of the degree of lung function impairment (FEV1 percentage predicted), with most severe impairment at the bottom and least severe at the top (Px: mild, Px: moderate, Px: severe lung function impairment). Samples from subjects with a severe CF lung function impairment tended to cluster in group H or M, whereas samples from subjects with mild-moderate impairment clustered in the L group. The microbial diversity (Shannon index) of samples by hierarchical cluster is presented in Supplementary Figure 5.
    • Figure S4 - Pearson's correlation demonstrating the relationship between the relative abundance of Pseudomonas (genus) and P. aeruginosa colony forming units (CFU) per gram of sputum, determined by RT-qPCR.
    • Figure S5 - Community diversity (Shannon index) of samples by hierarchical clustering group. The greatest diversity is seen in the L group, with low diversity seen in the H group.
    • Figure S6 - Relative abundance of, A. aerobic and, B. anaerobic bacteria for each CF subject. The colour indicates the hierarchical clustering group of the subjects at time-point 1 (red: group H, orange: group M, green: group H, grey: unknown [no sample at time-point 1])
  • Disclosures

    Files in this Data Supplement:

    • G. Anderson
    • A. Badrick
    • S. Bell
    • L. Krause
    • D. Reid
    • D. Smith
    • M. Zakrzewski
Next
Back to top
Vol 62 Issue 3 Table of Contents
European Respiratory Journal: 62 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics
Daniel J. Smith, Alison C. Badrick, Martha Zakrzewski, Lutz Krause, Scott C. Bell, Gregory J. Anderson, David W. Reid
European Respiratory Journal Jan 2014, erj02030-2013; DOI: 10.1183/09031936.00203013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics
Daniel J. Smith, Alison C. Badrick, Martha Zakrzewski, Lutz Krause, Scott C. Bell, Gregory J. Anderson, David W. Reid
European Respiratory Journal Jan 2014, erj02030-2013; DOI: 10.1183/09031936.00203013
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • StO2 during weaning from mechanical ventilation
  • Automated quantification of radiological patterns predicts IPF survival
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society